SERUM METABOLITES AS BIOMARKERS IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE

被引：0
|
作者：
Meier, C. [1 ]
Freiburghaus, K. [2 ]
Bovet, C. [2 ]
Schniering, J. [1 ]
Distler, O. [1 ]
Nakas, C. [2 ,3 ]
Maurer, B. [1 ]
机构：
[1] Univ Hosp Zurich, Dept Rheumatol, Ctr Expt Rheumatol, Zurich, Switzerland
[2] Univ Bern, Bern Univ Hosp, Univ Inst Clin Chem, Inselspital, Bern, Switzerland
[3] Univ Thessaly, Sch Agr Sci, Lab Biometry, Dept Agr Crop Prod & Rural Environm, Thessaly, Greece
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.702
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0333
引用
收藏
页码：1108 / 1108
页数：1
相关论文
共 50 条
  • [1] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    C. Meier
    K. Freiburghaus
    C. Bovet
    J. Schniering
    Y. Allanore
    O. Distler
    C. Nakas
    B. Maurer
    [J]. Scientific Reports, 10
  • [2] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    Meier, C.
    Freiburghaus, K.
    Bovet, C.
    Schniering, J.
    Allanore, Y.
    Distler, O.
    Nakas, C.
    Maurer, B.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Elhai, Muriel
    Hoffmann-Vold, Anna Maria
    Avouac, Jerome
    Pezet, Sonia
    Cauvet, Anne
    Leblond, Agathe
    Fretheim, Havard
    Garen, Torhild
    Kuwana, Masataka
    Molberg, Oyvind
    Allanore, Yannick
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (06) : 972 - 982
  • [4] Are serum biomarkers useful in the management of systemic sclerosis-associated interstitial lung disease?
    Proudman, Susanna M.
    Corte, Tamera J.
    [J]. RESPIROLOGY, 2021, 26 (05) : 406 - 408
  • [5] Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
    Bonhomme, Olivier
    Andre, Beatrice
    Gester, Fanny
    de Seny, Dominique
    Moermans, Catherine
    Struman, Ingrid
    Louis, Renaud
    Malaise, Michel
    Guiot, Julien
    [J]. RHEUMATOLOGY, 2019, 58 (09) : 1534 - 1546
  • [6] Towards the use of serum biomarkers in routine management of systemic sclerosis-associated interstitial lung disease
    Elhai, Muriel
    Mihai, Carina
    [J]. RHEUMATOLOGY, 2024, 63 (04) : 910 - 911
  • [7] THE PERFORMANCE OF SERUM BIOMARKERS IN PREDICTING MORTALITY AND DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Parker, Matthew
    Jee, Adelle
    Nikpour, Mandana
    Hansen, Dylan
    Stevens, Wendy
    Kenna, Tony
    Proudman, Susanna
    Youssef, Peter
    Sahhar, Joanne
    Corte, Tamera
    [J]. INTERNAL MEDICINE JOURNAL, 2023, 53 : 7 - 7
  • [8] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [9] Systemic sclerosis-associated interstitial lung disease
    Perelas, Apostolos
    Silver, Richard M.
    Arrossi, Andrea, V
    Highland, Kristin B.
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (03): : 304 - 320
  • [10] Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease
    Bruni, Cosimo
    Occhipinti, Mariaelena
    Pienn, Michael
    Camiciottoli, Gianna
    Bartolucci, Maurizio
    Bosello, Silvia Laura
    Payer, Christian
    Balint, Zoltan
    Larici, Anna Rita
    Tottoli, Alessandra
    Tofani, Lorenzo
    De Lorenzis, Enrico
    Lepri, Gemma
    Bellando-Randone, Silvia
    Spinella, Amelia
    Giuggioli, Dilia
    Masini, Francesco
    Cuomo, Giovanna
    Lavorini, Federico
    Colagrande, Stefano
    Olschewski, Horst
    Matucci-Cerinic, Marco
    [J]. RHEUMATOLOGY, 2023, 62 (02) : 696 - 706
12345